Shionogi
Xin Dang has a diverse work experience spanning over two decades. They began their career at GSK in 2001 as a Brand Manager and eventually worked their way up to become the Global Marketing Director for Allergy and Respiratory Health. In this role, they led a $0.5B OTC franchise by developing and nurturing a distinctive brand vision, strategy, positioning, portfolio, and pipeline. Xin also served as a Category Marketing Director for OTC Wellness and managed P&L for multiple US brands, including FiberChoice, Beano, TUMS, and OsCal.
In 2019, Xin joined Shionogi Inc. as the Global Commercial Lead for CNS/Cognition. In this position, they are responsible for leading the global launch preparation for a first-in-class rare disease treatment. Xin also plays a crucial role in developing, enhancing, and deploying commercial excellence programs to enhance the global brand planning process.
Xin Dang holds a Master of Business Administration (MBA) degree in Marketing from Emory University's Goizueta Business School. Prior to that, Xin completed a Bachelor of Arts (BA) degree in International Business from the University of International Business and Economics. The specific years of enrollment are not specified.
This person is not in any teams
Shionogi
10 followers
Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages their science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need, including chronic liver disease.